BIOFRONTERA AG |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.354 EUR | +5.99% |
|
+7.05% | -16.71% |
| 11/03 | Biofrontera Files Prospectus for Potential Secondary Stock Offerings | MT |
| 05/03 | Medicus Pharma Names COO | MT |
Chart calendar Biofrontera AG
9df65e112ceb284d55d44fd4bb9f.G98Wmq1hTgJAHBecwkhDHa1Lhly6elYrO-rT3lqiU-I.Yp1iou8MOmEpJVnQqiohb848wg3OKRhGb4-lphv4EKZr62Lj_g4maDJFUg~a87dc22ec5a787a297548c7ef1b13865
Upcoming events on Biofrontera AG
Past events on Biofrontera AG
| 25/04/2024 | Q4 2023 Earnings Release (Projected) |
| 31/08/2023 01:30 pm | Q2 2023 Earnings Release |
| 20/06/2023 03:00 pm | Annual General Meeting |
| 31/05/2023 05:30 pm | Q1 2023 Earnings Call |
| 31/05/2023 03:00 pm | Q1 2023 Earnings Release |
| 28/04/2023 02:50 am | Q4 2022 Earnings Release |
| 23/11/2022 | Q3 2022 Earnings Release |
| 28/10/2022 | Rights Issue: 1 new share @ 1 EUR for 8 existing shares |
| 23/08/2022 02:30 pm | Annual General Meeting |
| 18/08/2022 | Interim 2022 Earnings Release |
| 19/05/2022 05:30 pm | Q1 2022 Earnings Call |
| 17/05/2022 07:50 pm | Q1 2022 Earnings Release |
| 02/05/2022 05:30 pm | FY 2021 Earnings Call |
| 28/04/2022 | FY 2021 Earnings Release |
| 14/12/2021 02:30 pm | Annual General Meeting |
| 22/11/2021 | Analyst Conference |
| 18/11/2021 06:30 pm | Q3 2021 Earnings Call |
| 18/11/2021 03:30 am | Q3 2021 Earnings Release |
| 20/08/2021 05:30 pm | Interim 2021 Earnings Call |
| 19/08/2021 09:16 pm | Interim 2021 Earnings Release |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 21,1 21,1 -0.12% | 31,3 31,3 0.05% | 30,3 30,3 0.04% | 28,8 28,9 -0.22% | 25,7 27,0 -4.67% |
|
EBITDA Million EUR | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | -32,1 -31,2 -2.73% | 1,87 3,90 -52.08% |
|
EBIT Million EUR | Released Forecast Spread | -18,5 -15,4 -19.75% | -23,4 -23,8 1.64% | -7,61 -9,43 19.32% | -35,3 -35,4 0.17% | 1,12 3,10 -63.74% |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -19,3 -14,6 -31.68% | -4,78 -5,25 9.01% | -12,7 -12,8 0.8% | 35,7 -37,8 194.52% | -43,2 -42,1 -2.64% |
|
Net income Million EUR | Released Forecast Spread | -9,58 -11,3 15.22% | -7,36 -5,25 -40.15% | -13,0 -13,1 0.33% | 38,3 -32,1 219.37% | -44,2 -42,1 -4.91% |
|
EPS EUR | Released Forecast Spread | -0,20 -0,25 18.92% | -0,16 -0,12 -33.33% | -0,24 -0,28 12.73% | 0,68 -0,46 247.83% | -0,77 -0,59 -30.51% |
| Announcement Date | 29/04/19 | 20/04/20 | 12/04/21 | 30/04/22 | 28/04/23 |
Quarterly results
| Fiscal Period | December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 |
|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 5,38 6,75 -20.31% | 10,3 10,4 -0.83% | 6,57 9,70 -32.31% | 8,51 10,4 -18.17% |
|
EBIT Million EUR | Released Forecast Spread | -4,99 -4,50 -10.91% | -22,8 -22,8 0.14% | 1,15 | |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -5,38 -4,90 -9.88% | 50,3 -23,3 315.93% | -28,1 -5,10 -450.98% | -7,96 -5,40 -47.43% |
|
Net income Million EUR | Released Forecast Spread | -5,80 -4,90 -18.37% | 53,0 -23,3 327.42% | -28,1 -5,10 -450.98% | -8,65 -5,40 -60.09% |
|
EPS EUR | Released Forecast Spread | -0,10 -0,09 -11.11% | |||
| Announcement Date | 17/11/21 | 30/04/22 | 17/05/22 | 19/08/22 |
More events
Past sector events for Biofrontera AG
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- B8F Stock
- Calendar Biofrontera AG
